ALEMBIC PHARMACEUTICALS
Back to Income Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹7,345 Cr | ₹6,672 Cr | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr |
What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹7,345 Cr |
| Mar2025 | ₹6,672 Cr |
| Mar2024 | ₹6,229 Cr |
| Mar2023 | ₹5,653 Cr |
| Mar2022 | ₹5,306 Cr |
How is Revenue of ALEMBIC PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,345 Cr | 10.08 | |
| Mar2025 | ₹6,672 Cr | 7.12 | |
| Mar2024 | ₹6,229 Cr | 10.19 | |
| Mar2023 | ₹5,653 Cr | 6.54 | |
| Mar2022 | ₹5,306 Cr | - | |
Compare Revenue of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹15,748.6 Cr | -3.6% | -1% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -3.6% |
-1% |
-12.1% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses